• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以SARIFA和肿瘤芽生为特征的局部侵袭模式在食管腺癌和鳞状细胞癌中存在差异且具有不同的预后意义。

Local Invasion Patterns Characterized by SARIFA and Tumor Budding Differ and Have Distinct Prognostic Significance in Esophageal Adenocarcinoma and Squamous Cell Carcinoma.

作者信息

Jakab Ákos, Zarándy Levente, Kocsmár Ildikó, Várkonyi Tibor, Kenessey István, Szijártó Attila, Kiss András, Vass Tamás, Lotz Gábor, Kocsmár Éva

机构信息

Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.

Department of Urology, Semmelweis University, Üllői Str. 78/b, H-1082 Budapest, Hungary.

出版信息

Cancers (Basel). 2024 Sep 13;16(18):3144. doi: 10.3390/cancers16183144.

DOI:10.3390/cancers16183144
PMID:39335115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430286/
Abstract

Both esophageal squamous cell carcinoma (ESQCC) and adenocarcinoma (EAC) are known to have poor prognosis. We aimed to investigate the invasion front areas of 57 ESQCC and 43 EAC cases to find histological signs of metastatic progression. Tumor cell clusters with different cell counts, including tumor buds (TBs) and poorly differentiated clusters (PDCs), were assessed. The presence of the recently described Stroma AReactive Invasion Front Area (SARIFA) phenomenon, which defines a direct contact between tumor cells and adipocytes, was more frequently observed in EAC than in ESQCC ( = 0.004). In adenocarcinomas, a higher prevalence of SARIFA was observed in tumors with a higher number of small clusters (TBs and small PDCs; < 0.001); furthermore, both the high number of TBs ( = 0.016) and the presence of SARIFA ( = 0.001) correlated with a higher pT stage. SARIFA positivity in EAC ( = 0.011) and high TB in ESQCC ( = 0.0006) were found to be independent prognostic factors for lymph node metastases. Moreover, in ESQCC, the higher absolute number of both TBs and PDCs was associated with shorter overall survival ( = 0.0269 and = 0.0377, respectively). Our results suggest that the histological subtypes of esophageal cancer behave differently, namely, that different features of the invasion front are of prognostic significance.

摘要

食管鳞状细胞癌(ESQCC)和腺癌(EAC)均已知预后较差。我们旨在研究57例ESQCC和43例EAC病例的浸润前沿区域,以寻找转移进展的组织学迹象。评估了具有不同细胞数量的肿瘤细胞簇,包括肿瘤芽(TBs)和低分化簇(PDCs)。最近描述的基质反应性浸润前沿区域(SARIFA)现象,即肿瘤细胞与脂肪细胞之间的直接接触,在EAC中比在ESQCC中更频繁地观察到( = 0.004)。在腺癌中,在具有较高数量小簇(TBs和小PDCs)的肿瘤中观察到更高的SARIFA患病率( < 0.001);此外,高数量的TBs( = 0.016)和SARIFA的存在( = 0.001)均与更高的pT分期相关。EAC中的SARIFA阳性( = 0.011)和ESQCC中的高TB( = 0.0006)被发现是淋巴结转移的独立预后因素。此外,在ESQCC中,TBs和PDCs的更高绝对数量均与较短的总生存期相关(分别为 = 0.0269和 = 0.0377)。我们的结果表明,食管癌的组织学亚型表现不同,即浸润前沿的不同特征具有预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/b583fddc2b14/cancers-16-03144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/1f09a104d598/cancers-16-03144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/246e799234dc/cancers-16-03144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/b583fddc2b14/cancers-16-03144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/1f09a104d598/cancers-16-03144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/246e799234dc/cancers-16-03144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc04/11430286/b583fddc2b14/cancers-16-03144-g003.jpg

相似文献

1
Local Invasion Patterns Characterized by SARIFA and Tumor Budding Differ and Have Distinct Prognostic Significance in Esophageal Adenocarcinoma and Squamous Cell Carcinoma.以SARIFA和肿瘤芽生为特征的局部侵袭模式在食管腺癌和鳞状细胞癌中存在差异且具有不同的预后意义。
Cancers (Basel). 2024 Sep 13;16(18):3144. doi: 10.3390/cancers16183144.
2
Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective Study.基质反应性侵袭前沿区域(SARIFA)——一种新的易于确定的结肠癌生物标志物——一项回顾性研究的结果
Cancers (Basel). 2021 Sep 29;13(19):4880. doi: 10.3390/cancers13194880.
3
The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.基质反应性侵袭前沿区(SARIFA)作为一种新的脂质驱动型癌症预后生物标志物的概念在胰腺导管腺癌中成立。
BMC Cancer. 2024 Jun 26;24(1):768. doi: 10.1186/s12885-024-12519-9.
4
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes.基质反应性侵袭前沿区(SARIFA)——一种与促进肿瘤生长的脂肪细胞相关的胃癌新预后生物标志物。
J Pathol. 2022 Jan;256(1):71-82. doi: 10.1002/path.5810. Epub 2021 Oct 22.
5
Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response.基质反应性浸润前沿区(SARIFA)在胃癌中证明具有预后相关性,其基础是肿瘤-脂肪细胞相互作用,表明免疫反应发生改变。
Gastric Cancer. 2024 Jan;27(1):72-85. doi: 10.1007/s10120-023-01436-8. Epub 2023 Oct 24.
6
Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.基质反应性侵袭前沿区(SARIFA)预测胃和胃食管交界处腺癌预后不良:一项验证研究。
Virchows Arch. 2024 Sep;485(3):527-534. doi: 10.1007/s00428-024-03826-4. Epub 2024 May 15.
7
The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients.基质反应性侵袭前沿区域(SARIFA)、瓦伯格亚型与生存率之间的关系:来自大量结直肠癌患者前瞻性系列研究的结果
Cancer Metab. 2024 Jul 11;12(1):21. doi: 10.1186/s40170-024-00349-z.
8
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.基质反应性浸润前沿区域(SARIFA):结直肠癌患者的一种新型组织病理学生物标志物及其与腔内肿瘤比例的关联
Transl Oncol. 2024 Jun;44:101913. doi: 10.1016/j.tranon.2024.101913. Epub 2024 Apr 10.
9
Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA).患有基质反应性浸润前沿区域(SARIFA)的结直肠癌患者自然杀伤细胞的改变
Cancers (Basel). 2023 Feb 3;15(3):994. doi: 10.3390/cancers15030994.
10
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.SARIFA 作为一种新的组织病理学生物标志物,与不良的临床病理特征、促进肿瘤的脂肪酸代谢相关,并且可能预测 pT3a 前列腺癌的转移模式。
BMC Cancer. 2024 Jan 12;24(1):65. doi: 10.1186/s12885-023-11771-9.

引用本文的文献

1
Stroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria.1298例pT3/pT4期结直肠癌中的基质反应性浸润前沿区域(SARIFA):一个补充既定形态学标准的强大预后参数。
Histopathology. 2025 Sep;87(3):464-473. doi: 10.1111/his.15501. Epub 2025 Jul 4.
2
Unveiling Another Dimension: Advanced Visualization of Cancer Invasion and Metastasis via Micro-CT Imaging.揭示另一个维度:通过微型计算机断层扫描成像对癌症侵袭和转移进行高级可视化
Cancers (Basel). 2025 Mar 28;17(7):1139. doi: 10.3390/cancers17071139.

本文引用的文献

1
Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.基质反应性侵袭前沿区(SARIFA)预测胃和胃食管交界处腺癌预后不良:一项验证研究。
Virchows Arch. 2024 Sep;485(3):527-534. doi: 10.1007/s00428-024-03826-4. Epub 2024 May 15.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
[Changes in the treatment of upper gastrointestinal tumors].
[上消化道肿瘤治疗的变化]
Orv Hetil. 2024 Feb 11;165(6):203-210. doi: 10.1556/650.2024.32983.
4
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.基质反应性浸润前沿区域(SARIFA)改善了来自MAGIC和ST03试验的接受围手术期化疗的食管癌和胃癌患者的预后风险分层。
Br J Cancer. 2024 Feb;130(3):457-466. doi: 10.1038/s41416-023-02515-4. Epub 2023 Dec 20.
5
Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response.基质反应性浸润前沿区(SARIFA)在胃癌中证明具有预后相关性,其基础是肿瘤-脂肪细胞相互作用,表明免疫反应发生改变。
Gastric Cancer. 2024 Jan;27(1):72-85. doi: 10.1007/s10120-023-01436-8. Epub 2023 Oct 24.
6
Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer.肿瘤芽生在胃癌中的预后能力优于低分化簇。
Cancers (Basel). 2022 Sep 28;14(19):4731. doi: 10.3390/cancers14194731.
7
Esophageal adenocarcinoma: A dire need for early detection and treatment.食管腺癌:早期检测和治疗的迫切需求。
Cleve Clin J Med. 2022 May 2;89(5):269-279. doi: 10.3949/ccjm.89a.21053.
8
Tumor cell budding in preoperative biopsies of esophageal and gastroesophageal junction carcinoma independently predicts survival in a grade-dependent manner.术前活检标本中肿瘤细胞巢的存在与食管胃交界部癌患者的生存独立相关,且这种相关性具有分级依赖性。
Surgery. 2022 Aug;172(2):567-574. doi: 10.1016/j.surg.2022.02.020. Epub 2022 Apr 11.
9
Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives.食管腺癌的外科治疗——当前标准与未来展望
Cancers (Basel). 2021 Nov 21;13(22):5834. doi: 10.3390/cancers13225834.
10
Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective Study.基质反应性侵袭前沿区域(SARIFA)——一种新的易于确定的结肠癌生物标志物——一项回顾性研究的结果
Cancers (Basel). 2021 Sep 29;13(19):4880. doi: 10.3390/cancers13194880.